Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04838691
Other study ID # zeynep
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 6, 2020
Est. completion date August 30, 2020

Study information

Verified date April 2021
Source Istanbul University-Cerrahpasa
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to test the effectiveness of interpersonal counseling in PMS symptom management in university students experiencing PMS symptoms.


Description:

People diagnosed with Premestrual Syndrome were identified through an online questionnaire. 80 people who were identified and accepted to study were divided into two groups as experiment and control. Initially, pre-menstrual screening tool, interpersonal relationship dimensions scale and perceived stress scale were applied to all groups. Then, 8 sessions of interpersonal counseling, each lasting 40 minutes, were applied to the experimental group for 2 months. Scales were repeated for both groups after the application was completed. Repeated measurements were made 3 months later.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date August 30, 2020
Est. primary completion date May 6, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: 1. According to the Pre-menstrual Symptom Screening Instrument, which is located in the group living with AES (Pre-Mental Syndrome) 2. between the ages of 18-30 3. Menstruating at regular intervals for at least 2 years (21-35 days) 4. Those who have never given birth 5. Speak and understand Turkish 6. It will consist of people who have not received antidepressant, oral contraceptive or hormone therapy for any reason. Exclusion Criteria: 1. Having a known gynecological disease (endometriosis, polycystic ovary, ...) 2. A known, ongoing physical health problem (diabetes, rheumatic disease, ...) 3. Any psychiatric disease diagnosed (psychotic disorder, mood disorder, anxiety disorder ...) 4. People who use cigarettes, alcohol or substances

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
interpersonal counseling
In the intervention group, it will be administered for 40 minutes for 8 weeks to people with symptoms of premenstrual syndrome.

Locations

Country Name City State
Turkey Istanbul University-Cerrahpasa Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University-Cerrahpasa

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Premenstrual Symptom Screening Tool Women will be divided into 3 different groups as a result of the points they get from PSST. The first group will consist of women who fully meet the PMDD criteria. These Women must have at least one of the four main symptom groups from the group A symptoms plus any of the 4 symptoms marked as moderate to severe on the instrument. In addition, he should have reported that at least one of the questions in group B was severe, and yes answers should be given to both questions in group C.The second group is the group that meets the PMS living criteria. These women are expected to have marked at least one of the 4 main symptoms as moderate to severe from the group A questions and any other 4 symptoms as moderate to severe to answer the group B questions as moderate to severe, and to answer yes to at least one question from the C group.The third group will be considered as the group with subthreshold symptoms consisting of those who do not meet the criteria for entering the other two groups. Baseline (beginning), Change from Baseline PMDD or PMS after 2 months, Change from Baseline PMDD or PMS after 5 months,
Secondary Scale Of Interpersonal Relationships Dimensions The scale, which consists of 53 items in total, has 4 sub-dimensions. These are Confirmation, addiction, empathy, trust in others, and emotional awareness.
The high score obtained from each sub-dimension of the scale indicates that the individual has more features evaluated by the relevant sub-dimension.
Baseline (beginning), Change from Baseline Sub-dimensions of Interpersonal Relationships Scale after 2 months, Change from Baseline Sub-dimensions of Interpersonal Relationships Scale after 5 months
Secondary Perceived stress scale The higher the total score, the more negative it is. Baseline (beginning), 2 months after beginning, 3 months after beginning
See also
  Status Clinical Trial Phase
Completed NCT02481973 - The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome Phase 2
Completed NCT00195559 - Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder Phase 3
Completed NCT00048854 - Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder Phase 1/Phase 2
Completed NCT00965562 - Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS) N/A
Completed NCT05349344 - Effect of Aerobic Exercise on Premenstrual Syndrome Symptoms (PMS). N/A
Recruiting NCT06146673 - A Multidimensional Study of Premenstrual Syndrome and Body Image
Recruiting NCT05836454 - The Soft Tissue Mobilization Techniques on PMS N/A
Completed NCT05499000 - The Effect of Emotional Freedom Technique on Premenstrual Syndrome N/A
Recruiting NCT06144073 - The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome N/A
Recruiting NCT06105567 - The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress N/A
Completed NCT03298607 - The Impact of Serelys PMS on Symptoms of PMS Phase 3
Recruiting NCT06176313 - Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms N/A
Recruiting NCT02562053 - Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? Phase 3
Completed NCT00229346 - Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients N/A
Completed NCT00516113 - A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria Phase 4
Completed NCT04901598 - Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome
Completed NCT05692479 - Premenstrual Syndrome and Physical Activity Self-Worth
Completed NCT05665972 - Effects of Mandala Coloring on Premenstrual Syndrome N/A
Not yet recruiting NCT06052722 - The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders N/A
Completed NCT05556252 - The Effect of Hydrogen-rich Water on Premenstrual Symptoms and Quality of Life N/A